New drug KBP-5074 tested for safety in Early-Stage trial
NCT ID NCT02653014
First seen Dec 26, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This early-stage study tested the safety and tolerability of a new drug called KBP-5074 in 26 adults, including healthy volunteers and people with mild to moderate kidney impairment. Researchers measured how the drug moves through the body and checked for side effects. The goal was to gather information needed to design larger future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research by Design, LLC
Evergreen Park, Illinois, 60805, United States
Conditions
Explore the condition pages connected to this study.